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Background: Approximately 1 in 5 pregnant women in the United Kingdom are obese. In addition to being
associated generally with poor health, obesity is known to be a contributing factor to pregnancy and birth
complications and the retention of gestational weight can lead to long term obesity.
This paper describes the protocol for a cluster randomised trial to evaluate whether a weight management
intervention for obese pregnant women is effective in reducing women’s Body Mass Index at 12 months following
birth.
Methods/design: The study is a cluster randomised controlled trial involving 20 maternity units across England and
Wales. The units will be randomised, 10 to the intervention group and 10 to the control group. 570 pregnant
women aged 18 years or over, with a Body Mass Index of +/=30 (kg/m2) and between 12 and 20 weeks gestation
will be recruited. Women allocated to the control group will receive usual care and two leaflets giving advice on
diet and physical activity. In addition to their usual care and the leaflets, women allocated to the intervention group
will be offered to attend a weekly 1.5 hour weight management group, which combines expertise from Slimming
World with clinical advice and supervision from National Health Service midwives, until 6 weeks postpartum.
Participants will be followed up at 36 weeks gestation and at 6 weeks, 6 months and 12 months postpartum.
Body Mass Index at 12 months postpartum is the primary outcome. Secondary outcomes include pregnancy
weight gain, quality of life, mental health, waist-hip ratio, child weight centile, admission to neonatal unit, diet,
physical activity levels, pregnancy and birth complications, social support, self-regulation and self-efficacy. A cost
effectiveness analysis and process evaluation will also be conducted.
Discussion: This study will evaluate the effectiveness of a theory-based intervention developed for obese pregnant
women. If successful the intervention will equip women with the necessary knowledge and skills to enable them to
make healthier choices for themselves and their unborn child.
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Obesity: the problem
The Foresight Report (2007) estimates by 2050, 50% of
women could be obese and National Health Service
(NHS) costs associated with obesity could be £10 billion
per annum [1]. Approximately 1 in 5 women attending
antenatal care in the United Kingdom (UK) are obese
[2,3] and this figure is likely to increase. In Europe and
the United States of America (US) between 20 and 40%
of women gain more weight during pregnancy than is
routinely advised [4]. Pregnancy is a significant factor in
the development of obesity in women. Many women re-
tain cumulative weight gained over several pregnancies
and women with high weight gain during pregnancy re-
tain more weight at follow-up [5-7]. Excess maternal
weight gain during pregnancy is also associated with
child obesity at 3 years and in adolescence [8,9]. This
suggests there is potential for influencing the mother’s
lifestyle and weight as well as the child’s weight.
Obesity has been linked to an increased risk of compli-
cations during pregnancy and birth including pregnancy-
induced hypertension [2,10], gestational diabetes mellitus
[2,11], increased emergency and elective caesarean section
rates [2,10], increased induction of labour rates [2,11],
venous thromboembolism [12] and increased postpartum
haemorrhage [2,13]. There are also increased risks for the
child including pre-term birth [2,11], shoulder dystocia
[14], admission to a neonatal unit [2,13], birth defects (e.g.
spina bifida, omphalocele) [14], still birth [2,13], macroso-
mia [2,15], fetal and neo-natal death and poor Apgar
scores [16]. Consequently, the NHS costs are significantly
higher in overweight and obese pregnant women com-
pared to women in the normal weight range. Antenatal
care costs may be 5–16 times higher in overweight and
obese women [2,17].
Obesity interventions
Clinicians are often uncomfortable dealing with their
patients’ obesity [18,19], referral options are limited and
few evidence based interventions to tackle obesity during
pregnancy exist. In addition, although the Institute of
Medicine (IOM) in the US has produced guidance on ap-
propriate pregnancy weight gain for obese or overweight
women this remains somewhat controversial as research
evidence is limited and the guidance is based on observa-
tional data [20,21]. UK guidance is also lacking [22].
In the wider population there is evidence that lifestyle
or behavioural interventions including modifications of
diet and/or physical activity can help with weight loss
even in the longer term [23-27]. However, interventions
often have limited effectiveness, are costly and weight
regain is common [23,27,28]. In the UK, the National
Institute for Health and Care Excellence (NICE) has sug-
gested that commercial weight management groups area treatment option for obese patients [29]. Trials of
commercial weight management groups have shown
these approaches to be effective in the short term
[30,31]. However, evidence for longer term effectiveness
is lacking.
With regard to pregnant obese or overweight women,
a recent large randomised controlled trial (RCT) found
no impact of a lifestyle intervention on gestational
weight gain (GWG) or on the proportion of women
whose weight gain was below or within IOM guidance
[32]. The intervention did not reduce the risk of large
for gestational age infants nor did it improve maternal
outcomes. However, the intervention was associated
with a reduction in the risk of birth weight above
4000 g. A recent high quality meta-analysis of RCTs of
interventions of diet and physical activity, alone or in
combination, which included studies where women were
obese, overweight and normal weight, found an overall
1.42 kg difference between intervention and control par-
ticipants in GWG (in favour of the intervention group)
[33]. For diet alone the difference was 3.84 kg. For inter-
ventions targeting obese or overweight women only the
reduction in GWG was 2.1 kg. This review also found
that reductions in pregnancy weight gain were not asso-
ciated with an increased rate of small for gestational age
babies. Interventions were associated with a lower risk
of pre-eclampsia and shoulder dystocia and there was a
trend towards a reduction in gestational diabetes, gesta-
tional hypertension and pre-term birth. However, the
quality of the evidence was low for clinical outcomes as
there was evidence of significant heterogeneity in the ef-
fect size, study level biases including issues with ran-
domisation, incomplete outcome data, blinding, as well
as risk of publication bias [33]. Other systematic reviews
and meta-analyses have also found lower GWG from
diet and physical activity interventions, but included
studies often had methodological limitations including
high loss to follow-up, small sample sizes and problems
with blinding [34-38]. A Cochrane review of interven-
tions to prevent excessive weight gain during pregnancy
concluded that due to small effect sizes and methodo-
logical limitations of studies no intervention could be
recommended for limiting excessive GWG [39].
With regards to postpartum weight loss, a recent sys-
tematic review including 12 trials indicated that a com-
bination of diet and exercise or diet alone can help
women lose weight in the postpartum period [40]. In
addition, women in intervention groups were more likely
to achieve a healthy weight. The authors did not find a
difference between the amount of weight lost between
the diet alone or diet and physical activity together. They
caution that weight loss was moderate and that there
were a number of methodological shortcomings in some
trials. They also noted that there was much variation in
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other systematic review also found that diet and super-
vised physical activity based interventions could lead to
greater postpartum weight loss of 1.5 kg in the interven-
tion compared to control group [41].
Diet and physical activity changes are key to weight loss
but trials usually include other behavioural components as
part of the intervention. The NICE guidance on obesity
[29] and the new draft guidance on behaviour change
[42,43] recommend self-monitoring and feedback, goal
setting, planning and social support. Self-monitoring is
important for successful behaviour change for weight loss
[44]. In a meta-analysis of behaviour change interventions
of physical activity and healthy eating, more effective in-
terventions were shown to combine self-monitoring with
at least one other technique derived from Control Theory
(e.g. intention formation, specific goal setting) [45]. Social
support is associated with improved weight loss as well as
an increase in people completing treatment and maintain-
ing weight loss [46,47]. Social support may offer benefits
such as encouragement, feedback, and role modelling or
peer pressure for healthy behaviours.
With regards to interventions to limit GWG, a recent
meta-analysis identified that behavioural intervention
components including providing information, motiv-
ational approaches, self-monitoring and rewards contin-
gent on success were important, and using these
alongside dietary interventions could be more effective
[48]. Authors of this review suggest that further research
is needed to identify the most effective behavioural com-
ponents for limiting GWG. Another systematic review
exploring lifestyle interventions which utilised goal set-
ting approaches found that successful interventions in-
cluded personalised goal setting for diet and physical
activity, self-monitoring and feedback [49]. However, the
authors highlighted a lack of theory in the design and
evaluation and methodological problems with many
studies including issues around blinding, high drop out
and lack of information on intervention fidelity. Finally,
a meta-analysis examining characteristics of successful
interventions to reduce GWG found that diet and phys-
ical activity interventions were effective in limiting
GWG. However, the authors identified that developing
an understanding of the processes that lead to behaviour
change and determining key behaviour change tech-
niques is difficult because of poor reporting of the con-
tent of interventions, alongside lack of measurement of
psychological determinants or behavioural outcomes.
They suggest that better description of theory and the
behavioural components of interventions, as well as
assessing behavioural outcomes and theorised mecha-
nisms of the effect of interventions is required [50].
The intervention being tested in this trial is a com-
plex intervention which includes many of the effectivecomponents described above [51]. The proposed inter-
vention is based on Social Cognitive Theory [52] and
Control Theory [53] and includes techniques associated
with these theories that have shown to be efficacious in
changing weight related behaviours in systematic reviews
and meta-analyses [26,44,45,54,55]. These include boost-
ing self-efficacy, goal setting, modelling, encouragement,
feedback and self-monitoring. Other elements of effect-
ive behaviour change such as action planning, problem
solving, tailoring and social support are also central to
the intervention.
Rationale
Pregnancy is a time of change in women’s lives and is a
potentially important point at which to influence women’s
health behaviours as well as those of other family mem-
bers [56]. Weight loss interventions with one individual
can have spin-off effects on other family members [57].
Therefore, intervening with pregnant women and equip-
ping them with the skills, knowledge and support neces-
sary to manage their weight effectively, both during their
pregnancy as well as after (thereby preventing excessive
weight gain during pregnancy and retention of weight), is
an important step in tackling obesity in this group.
An effective intervention would decrease obesity-
related health risks for the women, reduce the risk of
complications for mother and baby during childbirth
and reduce health service costs. This could have a long
term impact on not only the mother, but the child and
other family members, resulting in far reaching public
health benefits [56,57]. Although trials targeting GWG
or weight loss postpartum by using advice on diet and/
or physical activity have had some success [58,59], many
studies have methodological problems including issues
with randomisation and blinding, poor retention, incom-
plete follow-up data, small sample sizes, issues relating
to intervention fidelity, poor description of the interven-
tion and lack of a theoretical basis [58,60]. As such,
more evidence is required. This trial seeks to address
some of these methodological shortcomings, in that: it is
adequately powered; it is theory-based; moderators of
intervention effect are being measured; there are a num-
ber of different strategies in place to retain participants;
there is a detailed process evaluation assessing issues like
fidelity; and, there is a cost effectiveness analysis. As far
as we are aware no RCTs of pregnancy or postpartum
interventions have included an assessment of cost effect-
iveness. This trial will test a theory-based intervention
targeting longer term postpartum weight control as well
as weight gain during pregnancy.
Aim of the study
The primary aim is to assess whether a weight man-
agement intervention for obese pregnant women is
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(BMI) 12 months after giving birth.
Secondary aims include:
 to examine whether the intervention leads to lower
weight gain during pregnancy;
 to assess whether the intervention leads to fewer
complications during pregnancy, at birth and
postnatally;
 to examine the impact of the intervention on diet,
physical activity levels, health related quality of life,
mental health, self-efficacy, social support and breast
feeding;
 to examine the child’s weight gain;
 to examine mediators and moderators of change;
 to conduct a cost effectiveness analysis;
 to conduct a process evaluation to examine
participant views, drop out, fidelity, duration of
participation in the intervention and associated
factors.Methods/design
Ethical approval
The study will be conducted in accordance with the rec-
ommendations for physicians involved in research on
human participants adopted by the 18th World Medical
Assembly, Helsinki 1964 and later revisions. The study
has been approved by the Research Ethics Committee
for Wales (Reference number 09/MRE09/58).Design
The study is a cluster randomised controlled trial; the
maternity units, rather than individual participants, are
the units of randomisation. This is to minimise risk of
contamination of control participants through two po-
tential mechanisms. Firstly, the use of aspects of the
intervention with control participants by site midwives
who have been trained in study procedures and sec-
ondly, the passage of information regarding the inter-
vention between intervention and control participants
who are acquainted and attend the same maternity unit.
In addition to receiving usual NHS care, all study par-
ticipants will be provided with 2 study leaflets: 1) a Food
Standards Association eating during pregnancy leaflet
detailing foods which should be avoided during preg-
nancy and 2) an exercise during pregnancy leaflet detail-
ing recommended physical activity during pregnancy
and warning signs for when to stop exercise and seek
medical attention. Participants attending intervention
sites will also receive the HELP Study intervention
which is described below. Participants attending control
sites will only receive usual care and the leaflets.Study intervention
A logic model (shown in Figure 1) describing the theory
of the intervention was developed. This illustrates the key
inputs, outputs/behaviours and outcomes of the interven-
tion. Participants attending intervention sites will have the
opportunity to attend free, weekly, 1.5 hour weight man-
agement group sessions from the point of recruitment
(between 12 and 20 weeks gestation) up until 6 weeks
postpartum. At this time point they will receive one vou-
cher for a free Slimming World session at a ‘normal’ com-
munity group. They will also receive two intervention
phone calls from the Intervention Midwife at 3 and
6 months postpartum in order to provide longer term
support and encouragement. Long term intervention con-
tact helps sustain weight loss [61] and telephone support
can be effective in weight loss interventions [62]. Assum-
ing normal gestation of between 37 and 42 weeks and de-
pending on when women were recruited, the intervention
period will be up to 56 weeks in total.
The intervention sessions will be held in NHS Ante-
natal Clinics and will be run jointly by an NHS midwife
and a Slimming World consultant. There are four main
components of the intervention group sessions: 1)
healthy eating, 2) physical activity, 3) midwifery advice
and 4) behavioural component.
1) The healthy eating component
Slimming World, a major UK based commercial slim-
ming organisation has developed a flexible weight man-
agement and healthy eating programme called “Extra
Easy”, which follows current UK government recom-
mendations for a healthy diet including the “Eat Well
Plate”. The diet consists of a combination of different
food types: approximately 80% combined from fruit, veg-
etables, carbohydrates and protein; a smaller section for
milk and dairy; and an allowance for foods high in fat or
sugar. Other than limiting the intake of high fat or high
sugar foods, it is not a ‘restrictive’ diet. Pregnant women
are offered advice to encourage them to eat additional
healthy extras to ensure they have adequate calcium and
fibre intake. The programme utilises a “food optimising
system” to encourage adherence to the healthy eating
plan by considering and modifying energy density and
satiety, complemented by flexibility of food options.
2) The physical activity component
An individualised physical activity programme for
obese pregnant women was developed, based on The
Royal College of Obstetricians and Gynaecologists
guidelines for exercise in pregnancy [63]. Due to its
flexibility, ease and cost effectiveness, walking is the pri-
mary focus of the programme. Women will be provided
Figure 1 HELP Intervention Logic Model mapping the theory of the intervention.
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daily step counts for up to seven consecutive days at
various time points (baseline, 36 weeks gestation, 6 weeks
postpartum, 6 months postpartum and 12 months post-
partum). Women’s physical activity tends to decline as
pregnancy progresses and therefore the use of pedome-
ters is intended to act both as a motivational tool to en-
courage physical activity but also as a device to facilitate
self-monitoring of physical activity [64]. Step count tar-
gets will be individually agreed as part of the walking
intervention based on the following four study recom-
mendations and taking into consideration government
recommendations of 30 minutes of physical activity five
days a week which equates to 10000 steps per day [65].
All women will be encouraged to increase their step
counts gradually and as they feel able, as follows:
1 If previously sedentary, women will be advised to
aim to walk for 15 minutes, three times per week,
gradually increasing to 30 minutes, five times per
week.
2 If previously moderately physically active, a
maintenance activity plan will be negotiated based
on current step counts.3 If current step counts are greater than 10000 per
day, women will be advised to continue as able
within limits of comfort but not to start new
modalities of physical activity.
4 Following birth, women will be encouraged to
restart walking by gradually increasing daily step
counts as soon as they feel able. If delivery was
complicated, consultation with the women’s general
practitioner (GP) or midwife will be advised prior to
restarting the walking programme.
Women who are unable to complete the walking
programme will be encouraged to undertake alternative
recommended physical activity including swimming,
aquanatal and prenatal exercise classes, as appropriate.
In order to prevent over-exertion, women will be ad-
vised to only partake in moderate physical activity and
they will be asked to utilise the Borg Scale of Perceived
Exertion [66] each time they do any physical activity to
monitor levels of exertion. The Borg scale runs from 6
(no exertion) to 20 (maximum exertion), women will be
asked to engage in activity that is ‘somewhat hard’
(around 12-14 on the scale). Information regarding
warning signs to terminate exercise and when medical
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the majority of women, exercise is safe for both mother
and foetus throughout pregnancy and initiating moder-
ate exercise or continuing exercise is recommended in
most pregnancies [63].
3) The Midwife component
In addition to the usual NHS midwifery care, the
Intervention Midwife will be available to provide advice
regarding pregnancy and lifestyle, as well as provide add-
itional support in topics that women may be anxious
about like labour choices and breast feeding. Evidence
indicates that obese women are less likely than their
non-obese counterparts to breast feed [67] and breast
feeding is associated with reduced postpartum weight re-
tention [68]. The study is recommending a healthy, bal-
anced and unrestricted diet in pregnancy and therefore
foetal weight should not be impaired. Any woman in the
intervention group who loses a cumulative 3 kg over the
pregnancy will be reviewed by the Intervention Midwife
and asked to complete a 7-day food diary to confirm
that she is eating a healthy amount of food. If necessary,
the Intervention Midwife will refer the participant to
their obstetrician. Participant safety will be the responsi-
bility of the Intervention Midwife and any concerns will
be referred to an appropriate medical practitioner as per
normal protocol within the health care service.
Each session will include the following:
 The weighing session where each woman attending
will be weighed.
 New members will be welcomed and achievements
of the group reviewed.
 Nutritional advice will be given and the group will
discuss topics such as foods to avoid in pregnancy,
sharing ideas, recipes, eating out ideas. The women
will also be given access to Slimming World
resources such as recipe books and magazines.
 Physical activity advice will be given and the group will
review progress, share experiences, hints and tips, and
discuss local activities like aquanatal. All participants
will have their step targets reviewed monthly.
 Advice will be given on ailments during pregnancy
such as symphysis pubis dysfunction and sciatica.
 Discussion of a ‘Topic of the week’ such as ‘eating
for two’, nausea and breast feeding.
 Opportunities for one-to-one advice with the Inter-
vention Midwife or Slimming World consultant.4) Behavioural component
Practical skills and strategies for managing behaviour
change will be discussed in the groups. The SlimmingWorld approach (http://www.slimmingworld.com/health/
how-sw-works/image-therapy.aspx) provides motivational
support and aims to raise self-esteem and empower mem-
bers. It involves aspects of Transactional Analysis [69],
Motivational Interviewing [70] and Compassionate Mind
Theory [71]. The approach taken within the groups is
similar to Motivational Interviewing, as it is collaborative
and seeks to strengthen motivation for change, while
avoiding judgment or criticism. It uses empathy, accept-
ance and compassion to help individuals to overcome
barriers and identify goals and their own reasons or moti-
vators to change.
In the groups there will be a level of tailoring to indi-
viduals in terms of the diet and physical activity advice
and as described above, the participants will have the
opportunity to discuss these as well as plans and goals
individually with the Slimming World consultant or
Intervention Midwife, as well as within the wider group.
A number of behavioural strategies will be discussed and
encouraged during the group sessions these include;
self-monitoring, self-regulation, goal setting, problem
solving and action planning. Within the groups different
behaviours will be modelled both by the intervention
staff but also by other women in the group e.g. where
they have started aquanatal classes or started cooking
with fresh vegetables. The intervention staff will give
encouragement and feedback to the women not only on
their weight but also diet and physical activity and other
issues.
The key aims of the groups are to encourage goal
setting, self-monitoring and behavioural self-regulation,
improve motivation and boost self-efficacy and social
support. These are addressed directly by the Slimming
World approach. Intervention staff will also be trained
by the study team on the importance of encouraging
and supporting women with respect to these aims.
Women will be encouraged to weigh at least weekly and
to monitor and, if necessary, alter their eating and phys-
ical activity behaviours in relation to their goals. The
groups seek to enhance women’s motivation by provid-
ing positive feedback and by helping them set realistic
goals, problem solve and manage lapses or setbacks
appropriately. It is intended that the groups will improve
women’s self-efficacy by providing them with useful
information and by helping them develop the necessary
skills for a healthy lifestyle, but also by helping them
build on success and by giving them opportunities for
observing similar others succeeding (modelling) as well
as providing positive feedback on progress [72]. Social
support will be provided by other women within the
groups as the setting facilitates sharing experiences and
information, giving feedback, empathy and encourage-
ment as well as reinforcement of behaviours which may
help increase motivation. It also provides opportunities
John et al. BMC Public Health 2014, 14:439 Page 7 of 16
http://www.biomedcentral.com/1471-2458/14/439for role modelling, improved self-efficacy, instrumental
support (help), appraisal (e.g. affirmation) and peer pres-
sure for healthy behaviours.
Regular attendance at the groups will be encouraged
and participants will be contacted if they miss two or
more consecutive intervention group sessions, to try to
foster future attendance. Intervention group sessions will
be held at a convenient time to enhance attendance,
usually early evening.
The Intervention Midwives and Slimming World con-
sultants will attend a one day training workshop deliv-
ered by the study team and will receive a study manual
detailing all aspects of the intervention, in order to
ensure consistency in the delivery of the intervention
across all sites. In addition, intervention group sessions
will be observed by study team members to examine
intervention fidelity across sites.
Sample size
At the time we were developing the study we could find
no systematic reviews of lifestyle interventions in pregnant
women, so we based our sample size on a systematic
review of interventions with obese adults, which found a
mean weight loss of 7.9 kg (8.5%) during the first 6 months
of interventions involving diet and exercise, after which
weight was gradually regained, by 48 months a mean
weight loss of 3.9 kg (4%) was maintained [28]. Results for
trials which included only obese women (mean BMI+/=30
at baseline) demonstrated weight loss of a similar magni-
tude at 12 months [28]. In order for an individually rando-
mised trial to have 80% power to detect a moderate effect
size of 0.333 for a difference in BMI at 12 month follow-
up of 1.5 kg/m2 (SD = 4.5), at a 5% significance level, 143
women per group would be required. Little pertinent data
are available for the estimation of the intra-cluster correl-
ation coefficient (ICC). Assuming an ICC of 0.02, if 20
maternity units were recruited across England and Wales,
a variance inflation factor of 1.4 would result, so the total
sample size is therefore inflated to 400 to detect the differ-
ence stated above and we would require an average of 20
women per unit. This would allow for a variance inflation
factor of 1.4 (ICC = 0.02) [73]. In trials investigating
weight management interventions in pregnant women,
losses to follow-up range considerably from 5% to 38%
[58,59,74-76], therefore we have allowed for a drop out of
30% and intend to recruit 570 women.
Centre recruitment
Twenty maternity units across England and Wales will
be recruited, ensuring a spread of different demographic
areas, e.g. areas of high minority populations and low
socio-economic status. All units will use electronic ma-
ternity information systems, in order to facilitate collec-
tion of outcome data and will have at least 1500 birthsper year. We will exclude any centre currently running a
service similar to the HELP intervention.
Participant recruitment
570 pregnant women with a Body Mass Index (BMI)
of +/=30 aged 18 years or older and between 12 and
20 weeks gestation will be recruited. Potentially eligible
participants will be approached at their earliest antenatal
appointment by NHS midwives or researchers, who will
provide an information sheet and briefly describe the
study. The decision to approach women will not be
made by the midwife delivering the intervention. If
women are eligible and interested in participating, they
will be contacted by the research midwife (local Principal
Investigator (PI)) to discuss the study in greater detail and
arrange a baseline home visit where informed consent and
baseline measures will be taken.
The approaching midwife/researcher will provide the
women with a comprehensive information sheet prior to
the baseline visit and adequate time will be given for
them to read the material and to ask any questions they
have about the study. Women will be reminded that they
retain the right to withdraw consent for participation in
any aspect of the trial at any time without their routinely
available NHS care being affected. Midwives/researchers
will be trained in Good Clinical Practice and all study
procedures. The participant’s GP, named midwife and
obstetrician, if applicable, will be informed that she is
taking part in the study.
A screening form will be completed to record the num-
ber of women approached about the study, eligibility, and
at what stage women declined to take part in the study
(e.g. when first approached or at the consent stage).
Exclusion criteria
Women will be excluded from being recruited into the
study if they:
1) are unable to understand the intervention, e.g. have
insufficient understanding of spoken English;
2) have any detected pregnancy related complications
e.g. multiple pregnancy, foetal anomaly, current
antenatal, maternal or foetal complications,
recurrent miscarriage (three or more) or previous
pre-eclampsia;
3) have any previous medical complications e.g. cardiac
disease, serious respiratory disease including severe
asthma, diabetes mellitus, serious mental illness/
psychological illness, epilepsy requiring
anticonvulsant therapy or hypertension requiring
treatment;
4) have nutritional complications e.g. serious physical
or psychological disorders (eating disorders) or
previous surgery for weight problems;
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any of the outcome measures that are being
investigated in this study.
This list is not considered exhaustive. If the midwife
considers that the woman has other serious complica-
tions that would affect her suitability to participate in
the study, the midwife may at her discretion exclude the
woman from recruitment noting on the recruitment
form the reason why the woman has been excluded. If
medical or obstetric complications arise while a partici-
pant is involved in the study advice will be taken from
the woman’s lead obstetrician on whether she should
withdraw from the intervention. If a woman is with-
drawn on clinical grounds the study team will still
complete follow-up if the woman is willing.
Site randomisation
Sites will be randomised when all necessary approvals
are obtained. Randomisation will be completed to give
optimal balance for geographic region, maternity unit
size, ethnic mix and the proportion of the maternity unit
pregnant patient population with a BMI +/=30 [77-81].
A process of optimal allocation will be undertaken [79-81].
This will involve calculation of all possible allocations
and a balance statistic for each one. A proportion of all
allocations with the greatest degree of balance will be
identified and passed to the independent statistician on
the Trial Steering Committee (TSC) blinded to unit. He
will randomly select a single allocation. This will then
be returned to the trial statistician. The process of opti-
mal allocation will be carried out in two blocks of ten
sites with each block allocation being chosen by the
independent statistician from the 25% most optimal
allocations in each case. A statistician independent of
the study but within the South East Wales Trials Unit
will create random numbers for intervention/control arm
allocation. The rest of the trial team and the clinics them-
selves will be informed of allocation after site recruitment.
In the event of delayed approvals for the maternity
units such that it is not possible to randomise the sec-
ond block of 10 sites together, minimisation will be used.
A random component will be added to the minimisation
algorithm using an 80% weighted randomisation. The
allocations of the first block will be used to balance the
remaining sites [77,78].
Outcomes
All outcome measures are listed in Table 1 and mediator
measures in Table 2. Measures were selected following a
comprehensive literature search and consultation with ex-
perts in diet and physical activity. Evidence of reliability,
validity and sensitivity to change were considered in the
selection process. An important issue was completiontime to avoid excessive respondent burden as this could
affect follow-up rates. For most of the outcomes and for
the mediators there was a limited choice of measures and
the final choice was inevitably a compromise between evi-
dence of good psychometric properties and the resources
and time available to complete the assessments.
The primary outcome is maternal BMI at 12 months
postpartum. Secondary outcomes will include investiga-
tion into the impact of the intervention on gestational
weight gain, the child’s weight gain, complications dur-
ing pregnancy, at birth and postnatally, diet, physical
activity levels, health related quality of life, mental health
and breast feeding intentions. All staff collecting data
will be trained in administering the different outcome
measures as well as accurately measuring weight, height
and waist and hip circumference. Height will be mea-
sured once at baseline and used for all BMI calculations.
Information on both adverse events (AE) and serious
adverse events (SAE) will be collected in the study. Trial
sites, participants’ GPs and intervention staff are respon-
sible for reporting AEs and SAEs. They may also be re-
ported by participants and by staff completing follow-up.
In this trial cohort the following are expected to occur:
hospitalisation for normal birth or any antenatal, perinatal
or postnatal complications, termination of pregnancy for
foetal anomaly and hospitalisation for postnatal depres-
sion. Rates of AEs and SAEs are likely to be higher in this
group of obese women than the normal population of
pregnant women. There are no SAEs expected to be re-
lated to the study intervention.
Follow-up & drop out
Baseline data will be collected by local PIs. Follow-up data
will be collected by local PIs or research staff in each
centre, or network research staff. For units in Wales this
will be the Clinical Studies Officers employed by National
Institute for Social Care and Health Research Clinical
Research Collaboration (NISCHR CRC), in England the
research nurses employed by the Comprehensive Local
Research Networks (CLRN). The follow-up visits will be
completed in the participants’ home or at a location of
the participants’ choice. The follow-up appointments are
timed to occur at important milestones both pre and post-
natally: 36 weeks gestation, 6 weeks postpartum, 6 months
postpartum and 12 months postpartum.
Every effort will be made to reduce loss to follow-up:
women will be visited at a convenient location of their
choice for all follow-up appointments. In order to improve
response rates, participants will be contacted to rearrange
any missed follow-up appointments, participant-nominated
contacts will be collected at baseline in order to facilitate
contact at follow-up appointments, participants will be
posted study updates in the form of newsletters and follow-
up calendars, and each participant will be provided with a
Table 1 Measurement of Outcomes
Outcomes Measure When*
Primary outcome
Maternal weight expressed as BMI relative
to height measured at baseline
Calibrated adult scales & stadiometer B, 36w, 6p, 6 m, 12 m
Secondary outcomes
Antenatal and birth complications** Routinely collected data held in patient records Birth
Pregnancy weight gain Calibrated adult scales B, 36w
Waist circumference and waist-hip ratio Measuring tape 12 m
Child weight centile
(adjusted for birth weight and age)
Calibrated baby scales and measuring tape Birth, 6p, 6 m, 12 m
Admission to neonatal unit Patient records Birth
General mental health General Health Questionnaire (GHQ) 12 [82] B, 36w, 6p, 6 m, 12 m
Breast feeding intentions Study-developed questions 36w
Breast feeding behaviour and weaning Study-developed questions 6p, 6 m, 12 m
Self-reported physical activity 7 Day Physical Activity Recall (7 Day PAR) [83-85] B, 36w, 6p, 6 m, 12 m
Diet Dietary Instrument for Nutrition Education (DINE) [86]
(plus additional questions on fruit and vegetables, sugar, sweets)
B, 36w, 6p, 6 m, 12 m
Alcohol Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) [87] B, 36w, 6p, 6 m, 12 m
Smoking Study-developed questions B, 36w, 6p, 6 m, 12 m
Costs Participant resource use B, 36w, 6p, 6 m, 12 m
Health related quality of life EQ-5D (including visual analogue scale) [88] B, 36w, 6p, 6 m, 12 m
*B = baseline; 36w = 36 weeks gestation; 6p = 6 weeks postpartum; 6 m = 6 months postpartum; 12 m =12 months postpartum.
**gestational diabetes; pre-eclampsia; thrombosis; proportion staying within IOM guidance on weight gain in pregnancy [20]; form of pain relief; birth delivery
mode; gestation at delivery; induction of labour; shoulder dystocia, 3rd/4th degree perineal tear; postpartum bleeding or thrombosis; Apgar scores.
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follow-up. A HELP study website will be used to provide
study updates (http://medicine.cf.ac.uk/help-study/), and a
minimum dataset will be developed to collect follow-up
data by telephone for those participants who are unwilling
or unable to meet with the researcher.
In order to prevent resentful demoralisation in the
control group, each of these women will be offered
12 weeks normal community-based Slimming World
sessions free of charge after her 12 month follow-up
is complete. Any woman who undergoes a miscarriage,
stillbirth, neonatal death or termination of pregnancy
will be given an open option whether or not they wish
to continue participation in the study.
All site study staff including the Intervention Midwife
and Slimming World consultant will be visited by the
research team and updated via regular contact andTable 2 Measurement of Mediators
Mediators Measure
Social support Social Support Exercise and Eating Habits Scales [89] (pl
Self-efficacy Weight Efficacy Lifestyle Scale [90] and Multidimensiona
Self-regulation Shortened Self-Regulation Questionnaire [93]
Motivation Treatment Self-Regulation Questionnaire (for diet and p
(B = baseline; 36w = 36 weeks gestation; 6 m = 6 months postpartum; 12 m =12 monewsletters in order to encourage continued enthusiasm.
In addition, to prevent disappointment following ran-
domisation in the control sites, if results from the study
prove positive units allocated to the control group
will then be offered training for their midwives in the
intervention.
Process evaluation
A process evaluation will be conducted in line with the
framework suggested by Steckler and Linnan [95]. This
evaluation will utilise both qualitative and quantitative
data including data taken from focus groups, interviews,
site intervention group observations, session summaries.
The process evaluation model will include assessment of
eight components; these are context, reach, exposure, fi-
delity, recruitment, retention, contamination and theory
testing. The definition of some of these elements is lessWhen
us intervention specific social support questions) B, 36w, 6 m, 12 m
l Self efficacy for Exercise Scale [91,92] B, 36w, 6 m, 12 m
B, 36w, 6 m, 12 m
hysical activity) [94] B, 36w, 6 m, 12 m
nths postpartum).
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concepts, so these are defined here as used in this study.
“Context” includes information relating to different as-
pects of the context that the intervention was delivered
in. This was explored by addressing who delivered the
intervention and where it was delivered. The broader
context was considered in the qualitative work and
includes data on circumstances, skills, resources and
attitudes that may influence intervention effectiveness.
“Reach” is defined as the extent to which the target audi-
ence is reached by the intervention as well as whether
the intervention had ‘spillover’ effects on other people
not recruited in the trial. We were interested in explor-
ing whether it had any impact on the family and friends
of the participants. “Exposure” is defined as whether the
participants received the different elements of the in-
tervention and whether the participants implemented
the different elements as intended. “Fidelity” is defined
as the degree to which the Intervention Midwives and
Slimming World consultants delivered the intervention
as intended.
We will assess study attrition by intervention or con-
trol group as well as by site. We will compare those
dropping out with those remaining in the trial in terms
of demographics. We will attempt to obtain reasons for
dropout where possible and record these. Finally, we will
assess potential contamination between groups through
the interviews and focus groups as well as by obtaining
details of all other services or interventions that control
group participants accessed. Table 3 shows the key
sources of information used to explore the eight compo-
nents of the process evaluation.
A key method for assessing these components is via
the qualitative data collection i.e. qualitative interviews
with participants and focus groups with the staff deliver-
ing the intervention. Semi-structured interviews will
be completed with approximately 30 participants from
the intervention group, purposively sampled across sites
according to attendance levels at the intervention group
sessions and whether they lost weight or not. The inter-
views will be carried out at the end of the intervention
period (at approximately 6 months postpartum) and at
the end of the study (at approximately 12 months post-
partum). We will explore the participants’ views of the
intervention, barriers and facilitators, the impact of life
events on adherence to the intervention, importance of
social support, strategies, coping mechanisms and re-
sponses to relapses. We will interview a small sample of
participants who drop out of the intervention but who
are willing to be interviewed, to establish their views of
the intervention and reasons for discontinuing. We will
also conduct brief interviews with a sample of around 15
women from the control group about taking part in the
study and any lifestyle changes they made both duringand after pregnancy. The interviews will continue until
data saturation is reached.
Three intervention staff focus groups will be com-
pleted and will explore the intervention components, the
delivery of the intervention, intervention fidelity, partici-
pant adherence to the intervention, the recruitment
process, perceived challenges or barriers in implement-
ing the intervention and potential improvements to the
intervention or the training.
With regards to theory testing we developed a logic
model (this is shown in Figure 1) to explain the pro-
cesses by which the intervention brings about change
and we plan to test the theory of our intervention via
mediation analyses as well as through other aspects
of the process evaluation including participant inter-
views. Potential mediators including self-regulation, in-
trinsic motivation, self-efficacy and social support will be
assessed. The analyses will identify both the extent to
which the intervention was successful at changing these
mediators and the extent to which mediator change was
associated with change in BMI. Potential moderators
of intervention effect will be examined including de-
mographics, ethnicity, parity, mental health (also an
outcome), smoking status and weight loss history.Economic evaluation
The main evaluation will be a cost utility analysis asses-
sing between group differences in total costs against dif-
ferences in Quality Adjusted Life Years (QALY) derived
from the EQ-5D quality of life instrument [88]. This ap-
proach is preferred by the National Institute for Health
and Care Excellence (NICE) for the economic evaluation
of NHS interventions as resulting cost utility estimates
can be compared across unrelated health care interven-
tions (www.NICE.org.uk). However, as a generic meas-
ure, EQ-5D may not be sufficiently sensitive to capture
small changes in health-related quality of life in essen-
tially healthy participants. A secondary cost effectiveness
analysis will therefore be undertaken with BMI as the
effectiveness measure. Both analyses will be done from
an NHS perspective but as the HELP intervention might
substitute for other weight control interventions, patient
borne costs will also be assessed but will be reported
separately.
Resources for training intervention midwives and de-
livery of the intervention will be recorded prospectively
in relevant units and valued using standard methods
[96]. Participants’ use of NHS resources will be collected
by questionnaire from women in both arms of the trial
at baseline and all follow-up points specified above and
similarly valued. The questionnaire will also record pay-
ments for non-NHS weight loss/maintenance activities
and will include the EQ-5D questionnaire [88].
Table 3 Process Evaluation Elements
Process evaluation
component
Assessment
Context • Data collected on a site proforma detailing
site demographics, ethnicity, size, services
delivered etc.
• Data on those delivering the intervention
• Data from two site observations completed at
different time points in the intervention delivery
period using a structured observation guide.
• Contextual issues explored in the staff
focus groups and participant interviews
Reach • Attendance at the group sessions
• Comparison of characteristics of those
attending the intervention with those
not attending
• Reach explored in the staff focus
groups and participant interviews
Exposure • Number of group sessions delivered
• Data from group session summary forms
which describe those attending and the
content/timings of sessions
• Data from site observations (two per site)
• Attendance at group sessions
• Exposure and attendance explored in the
staff focus groups and participant interviews
• Data gathered on use of pedometers,
step targets and walking diary completion
Fidelity • Data from site observations (two per site)
• Data from group session summary forms
which describes how the intervention was
implemented at each session
• Fidelity explored in the staff focus groups
and participant interviews
Recruitment • Comparison of demographics of sites recruited
• Recruitment rates compared across sites in
terms of how many recruited, who is recruited
and also how quickly people are recruited
• Comparison of potentially eligible women
with those recruited using data from case
report forms and screening forms
• Recruitment issues explored in the staff
focus groups and participant interviews
Retention • Dropout by trial arm
• Dropout by site
• Comparison of demographics of those
dropping out with those remaining
Contamination • Participants asked what other services
control group utilised in case report forms
• Contamination explored in the staff
focus groups and participant interviews
Theory testing • Mediation analyses using questionnaire data
• Theoretical mediators explored in the staff
focus groups and participant interviews
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Quantitative analysis
The main analysis will be by intention to treat and
will compare the primary outcome of BMI at 12 months
postpartum in the intervention and control groups.
Multilevel modelling will be used to account for cluster-
ing within antenatal unit and individual effects. A two
level linear regression model will include baseline BMI
(measured at recruitment) as a covariate. Both levels will
be considered ‘random effects’ i.e. patients and units are
drawn randomly from a larger population of patients
and units. Cluster level variables include those used to
balance the randomisation: antenatal unit size; propor-
tion of women with BMI +/=30, geographic location and
ethnic mix.
For the BMI data, positively skew distributed form is
anticipated and will be checked prior to analysis. Log
transformation will be considered, not only to deal with
the non-normality but to allow interpretation of differ-
ences between arms in percentage terms. To further aid
clinical interpretation of the intervention effect, analysis
of log transformed weight at 12 months postpartum will
also be considered, with baseline log weight and log
height as covariates. The results can then be expressed
in terms of BMI or weight along with a 95% confidence
interval. The intra-cluster correlation (ICC) for the pri-
mary outcome will be calculated and reported.
Intention to treat analysis will be used for all second-
ary outcomes. Analysis of secondary outcomes will also
use multilevel modelling incorporating baseline scores as
covariates where appropriate. Two level linear regression
models will be used for outcomes such as pregnancy
weight gain and waist-to hip ratio and validated ques-
tionnaire scores, while logistic models will be used for
clinical event outcomes. 95% confidence intervals for the
intervention effect will be calculated. The ICC for each
secondary outcome will be calculated and reported.
The impact of individual demographic factors as well
as theoretical mediators (self-efficacy, social support,
intrinsic motivation and self-regulation) on the interven-
tion effect using interaction terms included in the main
analysis models will be examined. Individual demo-
graphic variables include age, ethnicity, smoking status,
previous weight loss history, psychological wellbeing and
social class. We also intend to carry out tests for medi-
ator variables [97].
As well as examining number of sessions attended,
patterns of missed sessions and compliance with the
intervention will also be explored. A complier average
causal effect (CACE) analysis will be carried out for the
primary outcome to assess the effect of the intervention
in those who complied [97,98]. An investigation of re-
quired minimum dose of intervention will be carried
out. A per- protocol analysis will include only those
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domised excluding those in the control arm attending
weight loss groups.
No formal subgroup analyses are planned. However,
exploratory analyses of the impact of social class, parity,
ethnicity (if numbers permit), smoking status and initial
BMI on the effect of the intervention will be carried out.
This will be achieved by fitting a subgroup by rando-
mised group interaction term to the multilevel model.
If the proportion of missing primary data is substantial
(more than 10%) a series of sensitivity analyses will be
carried out to determine the likely effects of missing data
[99-101]. The intention is to use multiple imputation
to generate complete datasets for analysis. Imputation
models will include those variables in the analytic model
plus any additional variables associated with missingness
and outcome. Self-reported weight (from the minimum
dataset) and Slimming World session weight data may
be used to replace missing weights where appropriate in
secondary analyses. Further sensitivity analyses may be
carried out to examine the effects of removing women
who are known to be pregnant at the 12 month postpar-
tum follow-up, as well as those who have recently given
birth to a second baby. The assumptions of all models
used for primary and secondary analysis will be checked.
Short and long term effects of the intervention can be
examined using repeated measures analysis of intermedi-
ate weight measurements. The difference in weight at
6 months postpartum will also be examined. The pro-
portion of participants who lost 5% of their weight
(weight at 6 months postpartum compared to baseline)
will be calculated for each arm. The difference between
groups will be examined to identify if they maintained
that loss. The association between subsets of clinical
outcomes will also be investigated and a total count of
all clinical outcome events will be calculated and com-
pared between trial arms. Individuals lost to follow-up
will be compared to those who complete follow-up to
identify potential sample bias.
Qualitative analysis
Interviews and focus groups will be audio recorded,
transcribed and checked by the researcher. Standard the-
matic analysis techniques will be employed. Transcripts
will be closely examined to identify themes and categories
[102]. Codes will be applied to these broad themes which
will then be broken down further into sub-codes. Agree-
ment on concepts and coding will be sought between
members of the research team to ensure reliability. Com-
monly expressed themes will be identified as well as
unusual cases. 20% of the data will be coded separately
by two team members to check reliability of the coding
process. Interviewing will be iterative; where new themes
emerge they will be incorporated into the interviewsand focus groups. Thematic analysis will be supported by
qualitative analysis software (NVIVO).
Economic analysis
As training can be regarded as an investment producing
a flow of benefits over time, training costs will be amor-
tised and expressed in equivalent annual cost terms.
Costs of delivering the intervention, including an element
for training, will be apportioned to the intervention group.
Mean differential costs between intervention and control
groups will be estimated. As cost data are often skewed,
tests for normality will be carried out and if data are
not normally distributed non-parametric analyses will
be used to carry out the comparison of costs between
the two arms of the trial. Economic comparisons be-
tween the two study arms will take account of the
cluster nature of the data.
Results of the cost utility analysis will be reported in
the form of an incremental cost utility ratio (incremental
cost/QALY). A series of one-way sensitivity analyses will
assess how sensitive results are to changes in key as-
sumptions. Probabilistic sensitivity analyses will be used
to quantify uncertainty around the estimates and cost
effectiveness acceptability curves will show the probabil-
ity of the intervention having an incremental cost utility
ratio below a range of acceptability thresholds [103].
In the secondary analysis, cost effectiveness will be
assessed using BMI as the effectiveness measure. Unless
the intervention is shown to be dominant (lower costs
greater effect) the resulting incremental cost effective-
ness ratio (incremental cost per unit difference in BMI)
can be compared with that of other weight management
programmes delivered to pregnant women.
Exploratory work will be carried out to model the
medium term effect of the intervention bearing in mind
the high degree of uncertainty in long term weight
patterns particularly among the obese [104].
Discussion
This trial will evaluate the effectiveness of a theory-
based intervention for obese pregnant women, which
combines dietary expertise from Slimming World, phys-
ical activity, and clinical advice and supervision from
midwives. The intervention aims to provide support to
enhance motivation and equip women with the neces-
sary knowledge and skills to enable them to make
healthier choices and control their weight gain during
pregnancy as well as maintain a healthy lifestyle postpar-
tum through healthy eating and physical activity.
The study is novel as, to our knowledge, no RCTs of
pregnancy or postpartum weight control interventions
have included an assessment of cost effectiveness and
there are no published trials of diet and physical activity
interventions that run through pregnancy and into the
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plicitly described the theoretical basis of the intervention
or measured the psychological mediators of the effect.
The cluster design was chosen to avoid the risk of
contamination, because midwives trained in the use of
the intervention could potentially use aspects with con-
trol participants and pregnant women resident in the
same area often know one other and could share study
information. Also in order to run effective groups the
cluster design is superior in terms of recruiting sufficient
numbers to ensure sessions can be delivered locally.
The study incorporates economic and process evalua-
tions as well as explicit testing of the theory of the inter-
vention. The process evaluation will allow us to explore
the impact of different aspects of the intervention and if
the trial does not show an effect it will allow us to ex-
plore possible reasons for this.
Protecting against bias
Staff in maternity units who volunteer for the study are
likely to be motivated in favour of the intervention,
which may result in disappointment in those subse-
quently allocated to the control group. In order to avoid
differential dropout between the experimental and con-
trol groups, we will offer the maternity units in the con-
trol group the opportunity to complete the training
programme after the follow-up period, should the inter-
vention prove to be successful. Careful characterisation
of the participating sites, clinicians and patients will be
undertaken to judge the external validity of the study
findings.
Outcome data will be collected by PIs or trained re-
searchers allied to the project. Due to the nature of the
study, it will be difficult for researchers collecting out-
come data to be blinded to the allocation of the women;
however no staff involved in delivering the intervention
will collect follow-up data.
The findings of this study will advance current know-
ledge in this field, both in terms of weight management
interventions for obese pregnant women as well as be-
haviour change theory. If the trial is successful, this
could alter the management of obese pregnant women
within the NHS. Potential outcomes of the intervention
may include fewer complications in pregnancy and post-
partum for both mother and baby as well as less trau-
matic deliveries. Improvements in the women’s physical
and psychological health and self-esteem may also result
from attendance at the intervention group sessions, and
from the physical activity aspect of the intervention, in-
dependent of any weight loss. Benefits to the women
may be long lasting. There is evidence that many women
retain weight gained during pregnancy. If this interven-
tion is successful this may impact on cumulative obesity
developing over several pregnancies. Women will alsobenefit from expanded healthcare choices (e.g. midwife
as opposed to consultant led care) in subsequent preg-
nancies, if a healthy lifestyle leads to a BMI within
normal limits.
Conclusions
Obesity in pregnancy is linked to poor health and in-
creased NHS costs. This intervention could potentially
have an impact on the women taking part during their
current pregnancy but it could also equip them with
weight management and healthy lifestyle skills they can
use in the future. Benefits to public health could be far
reaching; pregnancy is a time of significant change within
a family at which women who could benefit from weight
control are accessible and may be readily motivated, and
any change to lifestyle could influence families’ behaviour
in the longer term.
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